WILMINGTON, N.C., Dec. 15, 2021 /PRNewswire/ -- Alcami
Corporation, a leading pharmaceutical and biotech contract
development and manufacturing organization (CDMO), announced today
it has completed the acquisition of Masy Systems Inc. ("Masy" or
"Masy BioServices"), a preferred provider of cGMP Biostorage and
pharma support services. The financial terms of the transaction
were not disclosed.
"The acquisition of Masy adds complementary service offerings
and further reinforces Alcami's ambitious growth and expansion
initiatives," commented Patrick D.
Walsh, Chairman and CEO of Alcami.
Masy was founded in 1984 by entrepreneurs Laurie and John Masiello and operates three cGMP
Biostorage facilities in Massachusetts, all within 1-hour of
Boston and Cambridge, with a fourth facility coming
online in early 2022. The company offers secure and tightly
controlled cGMP temperature storage from -196˚C to 70˚C, including
all ICH stability conditions, for various materials including
vaccines, biopharmaceuticals, cell banks, tissues, compounds, and
medical devices. The company's pharma support services include
equipment calibration, large-scale validation and qualification
projects, SenseAnywhere monitoring solutions, and validation and
calibration equipment sales and rentals. Masy's additional pharma
support service operations are located in California, Pennsylvania, New
Jersey, and North
Carolina.
"We built an amazing company at Masy and are thrilled to partner
with the Alcami team, as our combined resources and capabilities
will result in enhanced support for our customers," commented Masy
co-founder Laurie Masiello. In
addition, Steve Lane will continue
in his current executive leadership role at Masy and commented, "I
look forward to the successful integration and continuing to build
a strong and enduring business."
Masy clients will gain immediate access to Alcami's
comprehensive service offerings ranging from analytical development
and testing to full drug product development and manufacturing,
both sterile fill-finish and oral solid dose. Similarly, Alcami's
extensive client base will have access to Masy's available and
growing cGMP Biostorage capacity and extensive pharma support
services.
About Alcami:
Alcami is a contract development
and manufacturing organization headquartered in North Carolina with over 40 years of
experience advancing products through every stage of the
development lifecycle. Leveraging four US-based scientific
campuses, Alcami serves pharmaceutical and biotech companies of all
sizes providing customizable and innovative solutions for
analytical development, clinical to commercial sterile and oral
solid manufacturing, packaging, microbiology, and environmental
monitoring services. Alcami's private equity ownership includes
Madison Dearborn Partners and Ampersand Capital Partners. For more
information, please visit alcaminow.com.
About Masy BioServices:
Masy, founded by
John and Laurie Masiello in 1984,
has provided quality solutions to the life sciences community for
nearly 40 years and meets rigorous qualifications for NVLAP
accreditation to ISO 17025:2017 as well as ISO 9001:2015
certification. Services include calibration of primary standards
and critical test equipment; validation and IQ/OQ/PQ of
environmental chambers, autoclaves, and thermal warehouse mapping;
and lab equipment rentals and sales. Masy offers premier cGMP
biorepository options, with secure and tightly controlled
temperature storage from -196˚C to 70˚C, including all ICH
stability conditions, for various materials including vaccines,
biopharmaceuticals, cell banks, tissues, compounds, and medical
devices. For more information, please visit masy.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/alcami-announces-the-acquisition-of-masy-bioservices-301444758.html
SOURCE Alcami Corporation